<?xml version="1.0" encoding="ASCII"?>
<!-- XBRL document created with Praxa -->
<!-- Copyright (c) 2026 Praxa LLC. All Rights Reserved.-->
<!-- Creation Date: 2026-09-28T09:02:19.0234+00:00 -->
<xs:schema targetNamespace="http://polyrizon-biotech.com/20260630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:plrz="http://polyrizon-biotech.com/20260630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:srt="http://fasb.org/srt/2026">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="plrz-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="plrz-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="plrz-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="plrz-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple" />
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/Cover" id="Cover">
        <link:definition>995300 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/CondensedConsolidatedBalanceSheetsUnaudited" id="CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>995301 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals" id="CondensedConsolidatedBalanceSheetsUnauditedParentheticals">
        <link:definition>995302 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/CondensedConsolidatedStatementsofComprehensiveLossUnaudited" id="CondensedConsolidatedStatementsofComprehensiveLossUnaudited">
        <link:definition>995303 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/CondensedConsolidatedStatementofChangesinShareholdersEquityUnauditedUnaudited" id="CondensedConsolidatedStatementofChangesinShareholdersEquityUnauditedUnaudited">
        <link:definition>995304 - Statement - Condensed Consolidated Statement of Changes in Shareholders&#8217; Equity (Unaudited) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" id="CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>995305 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/General" id="General">
        <link:definition>995306 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>995307 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/InvestmentinSharesandWarrants" id="InvestmentinSharesandWarrants">
        <link:definition>995308 - Disclosure - Investment in Shares and Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/IntangibleAssetNet" id="IntangibleAssetNet">
        <link:definition>995309 - Disclosure - Intangible Asset, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/ShareholdersEquity" id="ShareholdersEquity">
        <link:definition>995310 - Disclosure - Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/LossPerShare" id="LossPerShare">
        <link:definition>995311 - Disclosure - Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/FinancialIncomeNet" id="FinancialIncomeNet">
        <link:definition>995312 - Disclosure - Financial Income, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995313 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/AccountingPoliciesbyPolicyPolicies" id="AccountingPoliciesbyPolicyPolicies">
        <link:definition>996314 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/InvestmentinSharesandWarrantsTables" id="InvestmentinSharesandWarrantsTables">
        <link:definition>996315 - Disclosure - Investment in Shares and Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/IntangibleAssetNetTables" id="IntangibleAssetNetTables">
        <link:definition>996316 - Disclosure - Intangible Asset, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/ShareholdersEquityTables" id="ShareholdersEquityTables">
        <link:definition>996317 - Disclosure - Shareholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/LossPerShareTables" id="LossPerShareTables">
        <link:definition>996318 - Disclosure - Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/FinancialIncomeNetTables" id="FinancialIncomeNetTables">
        <link:definition>996319 - Disclosure - Financial Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/GeneralDetails" id="GeneralDetails">
        <link:definition>996320 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/InvestmentinSharesandWarrantsDetails" id="InvestmentinSharesandWarrantsDetails">
        <link:definition>996321 - Disclosure - Investment in Shares and Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/InvestmentinSharesandWarrantsScheduleofFairValueofInvestmentinWarrantsDetails" id="InvestmentinSharesandWarrantsScheduleofFairValueofInvestmentinWarrantsDetails">
        <link:definition>996322 - Disclosure - Investment in Shares and Warrants - Schedule of Fair Value of Investment in Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/InvestmentinSharesandWarrantsScheduleofChangesinInvestmentDetails" id="InvestmentinSharesandWarrantsScheduleofChangesinInvestmentDetails">
        <link:definition>996323 - Disclosure - Investment in Shares and Warrants - Schedule of Changes in Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/IntangibleAssetNetDetails" id="IntangibleAssetNetDetails">
        <link:definition>996324 - Disclosure - Intangible Asset, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/IntangibleAssetNetScheduleofChangesintheCarryingAmountoftheCompanysIntangibleAssetsDetails" id="IntangibleAssetNetScheduleofChangesintheCarryingAmountoftheCompanysIntangibleAssetsDetails">
        <link:definition>996325 - Disclosure - Intangible Asset, Net - Schedule of Changes in the Carrying Amount of the Company&#8217;s Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/ShareholdersEquityDetails" id="ShareholdersEquityDetails">
        <link:definition>996326 - Disclosure - Shareholders&#8217; Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/ShareholdersEquityScheduleofExpensesRecognizedDetails" id="ShareholdersEquityScheduleofExpensesRecognizedDetails">
        <link:definition>996327 - Disclosure - Shareholders&#8217; Equity - Schedule of Expenses Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/LossPerShareScheduleofLossandtheWeightedAverageNumberofOrdinarySharesDetails" id="LossPerShareScheduleofLossandtheWeightedAverageNumberofOrdinarySharesDetails">
        <link:definition>996328 - Disclosure - Loss Per Share - Schedule of Loss and the Weighted Average Number of Ordinary Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/LossPerShareScheduleofComputationofDilutedNetLossPerShareDetails" id="LossPerShareScheduleofComputationofDilutedNetLossPerShareDetails">
        <link:definition>996329 - Disclosure - Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/FinancialIncomeNetScheduleofFinancialIncomeNetDetails" id="FinancialIncomeNetScheduleofFinancialIncomeNetDetails">
        <link:definition>996330 - Disclosure - Financial Income, Net - Schedule of Financial Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://polyrizon-biotech.com/20260630/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
        <link:definition>996331 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="plrz_ScheduleOfLossAndTheWeightedAverageNumberOfOrdinarySharesAbstract" name="ScheduleOfLossAndTheWeightedAverageNumberOfOrdinarySharesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_ImpairmentLossOnInvestmentInWarrants" name="ImpairmentLossOnInvestmentInWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_InvestmentInWarrants" name="InvestmentInWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_April2026WarrantsMember" name="April2026WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_InvestmentInShares" name="InvestmentInShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_FinanceIncomeForRevaluationOfTheInvestment" name="FinanceIncomeForRevaluationOfTheInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_ScheduleOfComputationOfDilutedNetLossPerShareAbstract" name="ScheduleOfComputationOfDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_OptionsMember" name="OptionsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_IPOWarrantsMember" name="IPOWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_SeriesAWarrantsMember" name="SeriesAWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_ExchangeWarrantsMember" name="ExchangeWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_QuantumXLabsIncMember" name="QuantumXLabsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_NumberOfOrdinarySharesReceivedUponWarrantExercise" name="NumberOfOrdinarySharesReceivedUponWarrantExercise" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="plrz_FairValueRevaluationOfInvestmentInSharesAndWarrants" name="FairValueRevaluationOfInvestmentInSharesAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_StockIssuedDuringPeriodValueIssuedForExerciseofWarrants" name="StockIssuedDuringPeriodValueIssuedForExerciseofWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_StockIssuedDuringPeriodSharesIssuedForExerciseofWarrants" name="StockIssuedDuringPeriodSharesIssuedForExerciseofWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="plrz_UnauditedConsolidatedFinancialStatementsPolicyTextBlock" name="UnauditedConsolidatedFinancialStatementsPolicyTextBlock" type="dtr:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="plrz_Phase3ClinicalTrialsMember" name="Phase3ClinicalTrialsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_FDAMember" name="FDAMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_EURegulatoryBodyMember" name="EURegulatoryBodyMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_AdditionalJurisdictionClinicalMember" name="AdditionalJurisdictionClinicalMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_LicenseAgreementMember" name="LicenseAgreementMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_SciSparcMember" name="SciSparcMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_NumberOfOrdinarySharesReceived" name="NumberOfOrdinarySharesReceived" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="plrz_StatementOfIncomeLocationsBalanceAxis" name="StatementOfIncomeLocationsBalanceAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_IncomeStatementLocationsDomain" name="IncomeStatementLocationsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_ResearchAndDevelopmentExpensesMember" name="ResearchAndDevelopmentExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_GeneralAndAdministrativeExpensesMember" name="GeneralAndAdministrativeExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_PIPEPrefundedWarrantsMember" name="PIPEPrefundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_ProductBasisRate" name="ProductBasisRate" type="dtr:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="plrz_PercentageOfSublicenses" name="PercentageOfSublicenses" type="dtr:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="plrz_FairValueOfSharesToBeIssued" name="FairValueOfSharesToBeIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_ConsultantsMember" name="ConsultantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_PrefundedWarrants" name="PrefundedWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="plrz_OrdinaryHeldShare" name="OrdinaryHeldShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="plrz_TaurusGoldCorpMember" name="TaurusGoldCorpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_UnitsPurchaseShares" name="UnitsPurchaseShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="plrz_MeasurementInputNumberOfWarrantsMember" name="MeasurementInputNumberOfWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_MeasurementInputFairValueMember" name="MeasurementInputFairValueMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_PurchaseOfShares" name="PurchaseOfShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_ChangesInFairValueInvestmentInShares" name="ChangesInFairValueInvestmentInShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_ChangesInFairValueInvestmentInWarrants" name="ChangesInFairValueInvestmentInWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_PurchaseOfWarrants" name="PurchaseOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_GrossProceedsFromOfferingAndPrivatePlacement" name="GrossProceedsFromOfferingAndPrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_PIPEOrdinaryWarrantsMember" name="PIPEOrdinaryWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_ExchangeRateDifferencesInFinancialIncome" name="ExchangeRateDifferencesInFinancialIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_BankFees" name="BankFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="plrz_InvestmentInSharesAndWarrants" name="InvestmentInSharesAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_ExerciseOfWarrantsIntoOrdinaryShares" name="ExerciseOfWarrantsIntoOrdinaryShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_IPOWarrantsExchange" name="IPOWarrantsExchange" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="plrz_ScheduleOfExpensesRecognizedAbstract" name="ScheduleOfExpensesRecognizedAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_ShareholdersEquityDetailsTable" name="ShareholdersEquityDetailsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_TwoThousandTwentyOnePlanMember" name="TwoThousandTwentyOnePlanMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_IntangibleAssetNetDetailsTable" name="IntangibleAssetNetDetailsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_PreclinicalSafetyTestMember" name="PreclinicalSafetyTestMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_Phase1ClinicalTrialMember" name="Phase1ClinicalTrialMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_Phase2aClinicalTrialMember" name="Phase2aClinicalTrialMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_Phase2bClinicalTrialMember" name="Phase2bClinicalTrialMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="plrz_AdditionalOrdinaryShares" name="AdditionalOrdinaryShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="plrz_RestrictedStockUnitsGrantedFairValue" name="RestrictedStockUnitsGrantedFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
</xs:schema>
